{"id":20997,"date":"2016-05-06T10:52:12","date_gmt":"2016-05-06T09:52:12","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=20997"},"modified":"2016-05-06T10:52:12","modified_gmt":"2016-05-06T09:52:12","slug":"que-en-sabem-dels-farmacs-nous","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/","title":{"rendered":"Qu\u00e8 en sabem dels f\u00e0rmacs nous?"},"content":{"rendered":"<p>Cada any surten nous f\u00e0rmacs al mercat i el farmac\u00e8utic compta amb un ampli estoc de productes destinats a diferents simptomatologies i malalties. Com a professional sanitari, el farmac\u00e8utic ha de saber qu\u00e8 aporten de nou aquests f\u00e0rmacs per proporcionar el millor consell. Per ampliar informaci\u00f3 sobre les noves mol\u00e8cules aparegudes en els \u00faltims dos anys en el mercat en els grups terap\u00e8utics en qu\u00e8 hi ha hagut innovacions d\u2019\u00e0mbit d\u2019aplicaci\u00f3 a la farm\u00e0cia comunit\u00e0ria, el COFB va organitzar el\u00a0<b>cicle de quatre confer\u00e8ncies<\/b> \u201c<b>Qu\u00e8 en sabem dels f\u00e0rmacs nous?\u201d<\/b> que va tenir lloc el passat mes de febrer:<\/p>\n<ul>\n<li><b>Antidepressius, ansiol\u00edtics i f\u00e0rmacs per al tractament de l\u2019alcoholisme:<\/b> impartida per Rafael Maldonado, metge i catedr\u00e0tic de farmacologia del laboratori de neurofarmacologia de la Universitat Pompeu Fabra.\n<p><figure id=\"attachment_21021\" aria-describedby=\"caption-attachment-21021\" style=\"width: 298px\" class=\"wp-caption alignright\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/04\/cicle-farmacs-nous-COFB-maldonado.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\" wp-image-21021   \" alt=\"cicle-farmacs-nous-COFB-maldonado\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/04\/cicle-farmacs-nous-COFB-maldonado.jpg\" width=\"298\" height=\"199\" \/><\/a><figcaption id=\"caption-attachment-21021\" class=\"wp-caption-text\">Rafael Maldonado, a la sessi\u00f3 d&#8217;antidepressius, ansiol\u00edtics i f\u00e0rmacs per al tractament de l\u2019alcoholisme<\/figcaption><\/figure><\/li>\n<li><b>F\u00e0rmacs per tractar l\u2019MPOC i antiasm\u00e0tics:<\/b> impartida per Rosa Madridejos, farmac\u00e8utica d\u2019atenci\u00f3 prim\u00e0ria, i Montserrat Llord\u00e9s, metgessa de fam\u00edlia del CAP Terrassa Sud, ambdues de la M\u00fatua Terrassa.<\/li>\n<li><b>Patologies dermatol\u00f2giques de m\u00e9s prevalen\u00e7a i els nous f\u00e0rmacs corresponents. Vacuna herpes z\u00f2ster, f\u00e0rmacs per l\u2019herpes simple, per la ros\u00e0cia i per la queratosi act\u00ednica<\/b>: impartida per M. Jos\u00e9 Trib\u00f3, dermat\u00f2loga del Servei de Dermatologia de l\u2019Hospital del Mar, Parc de Salut Mar de Barcelona.<\/li>\n<li><b>F\u00e0rmacs per al tractament de la s\u00edndrome de l\u2019intest\u00ed irritable (SII):<\/b> impartida per Agust\u00edn Balboa, metge especialista en aparell digestiu del Centre M\u00e8dic Teknon.<\/li>\n<\/ul>\n<figure id=\"attachment_21020\" aria-describedby=\"caption-attachment-21020\" style=\"width: 253px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/04\/cicle-farmacs-nous-COFB-madridejos.jpg\"><img decoding=\"async\" class=\" wp-image-21020 \" alt=\"cicle-farmacs-nous-COFB-madridejos\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/04\/cicle-farmacs-nous-COFB-madridejos.jpg\" width=\"253\" height=\"168\" \/><\/a><figcaption id=\"caption-attachment-21020\" class=\"wp-caption-text\">Rosa Madridejos explicant quins s\u00f3n els f\u00e0rmacs per tractar l\u2019MPOC i antiasm\u00e0tics<\/figcaption><\/figure>\n<div class=\"box shadow\">L\u2019arsenal terap\u00e8utic disponible est\u00e0 renovant-se cont\u00ednuament i \u00e9s de gran import\u00e0ncia per al farmac\u00e8utic estar actualitzat per poder donar una atenci\u00f3 farmac\u00e8utica de qualitat. \u201cEn el cas dels medicaments inhalats, aquest fet esdev\u00e9 doblement necessari: d\u2019una banda, durant els darrers anys s\u2019han comercialitzat multitud de principis actius nous i, per tant, <strong>\u00e9s imprescindible per al farmac\u00e8utic con\u00e8ixer qu\u00e8 aporten i quin \u00e9s el seu lloc en terap\u00e8utica<\/strong>; d\u2019altra banda, <strong>la innovaci\u00f3 tamb\u00e9 ve determinada per l\u2019aparici\u00f3 de nous dispositius d\u2019administraci\u00f3 dels medicaments inhalats<\/strong>\u201d explica <strong>Rosa Madridejos<\/strong>, en refer\u00e8ncia a la sessi\u00f3 de f\u00e0rmacs per tractar l\u2019MPOC i antiasm\u00e0tics.<\/p>\n<p><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/04\/cicle-farmacs-nous-COFB-sala.jpg\"><img decoding=\"async\" class=\" wp-image-21022 alignright\" alt=\"cicle-farmacs-nous-COFB-sala\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/04\/cicle-farmacs-nous-COFB-sala-1024x573.jpg\" width=\"372\" height=\"208\" \/><\/a>En la sessi\u00f3 impartida al COFB es van revisar els nous f\u00e0rmacs inhalats comercialitzats aix\u00ed com les caracter\u00edstiques de tots els dispositius per a la seva administraci\u00f3. \u201cEn aquest sentit, el <strong>farmac\u00e8utic<\/strong> ha de poder constituir-se en un <strong>professional clau en l\u2019educaci\u00f3 del pacient i col\u00b7laborar en el seguiment farmacoterap\u00e8utic del pacient des de l\u2019oficina de farm\u00e0cia<\/strong>: comprovant la t\u00e8cnica inhalat\u00f2ria, valorant l\u2019efectivitat dels tractaments, incorporant les prefer\u00e8ncies dels pacients en la selecci\u00f3 del millor dispositiu, millorant l\u2019adher\u00e8ncia terap\u00e8utica, etc.\u201d matisa <strong>Montserrat Llord\u00e9s.<\/strong> <\/div>\n<figure id=\"attachment_21023\" aria-describedby=\"caption-attachment-21023\" style=\"width: 298px\" class=\"wp-caption alignright\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/04\/cicle-farmacs-nous-COFB-tribo.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-21023  \" alt=\"cicle-farmacs-nous-COFB-tribo\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/04\/cicle-farmacs-nous-COFB-tribo-1024x683.jpg\" width=\"298\" height=\"198\" \/><\/a><figcaption id=\"caption-attachment-21023\" class=\"wp-caption-text\">Ma. Jos\u00e9 Trib\u00f3, a la seva confer\u00e8ncia sobre patologies dermatol\u00f2giques de m\u00e9s prevalen\u00e7a i els nous f\u00e0rmacs corresponents<\/figcaption><\/figure>\n<div class=\"box shadow\">Pel que fa a la sessi\u00f3 de patologies dermatol\u00f2giques de m\u00e9s prevalen\u00e7a i els nous f\u00e0rmacs corresponents -vacuna herpes z\u00f2ster, f\u00e0rmacs per l\u2019herpes simple, per la ros\u00e0cia i per la queratosi act\u00ednica- <strong>M. Jos\u00e9 Trib\u00f3<\/strong> ens trasllada el seu parer: \u201ccrec que aquesta experi\u00e8ncia did\u00e0ctica i formativa \u00e9s de vital import\u00e0ncia, ja que vam tenir l\u2019oportunitat de con\u00e8ixer els nous f\u00e0rmacs de les patologies dermatol\u00f2giques de m\u00e9s prevalen\u00e7a. <strong>Aquests espais poden assegurar que tothom que participa es mantingui actualitzat i es faci coneixedor de les \u00faltimes eines de tractament de les que disposem<\/strong>\u201d. I afegeix: \u201cd&#8217;altra banda, est\u00e0 molt ben orientat als farmac\u00e8utics, ja que estan fent una gran tasca a la salut p\u00fablica i a la privada. <strong>Les sessions els permeten familiaritzar-se amb efectes adversos dels medicaments i adquirir actituds terap\u00e8utiques<\/strong> per explicar als pacients qualsevol dubte relacionat amb el seu tractament, ajudant aix\u00ed als metges que disposen de molt poc temps. En general, una experi\u00e8ncia molt enriquidora i tamb\u00e9 molt necess\u00e0ria\u201d.<\/div>\n<figure id=\"attachment_21035\" aria-describedby=\"caption-attachment-21035\" style=\"width: 298px\" class=\"wp-caption alignleft\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/04\/cicle-nous-farmacs-COFB-balboa-2.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-21035 \" alt=\"cicle-nous-farmacs-COFB-balboa (2)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/04\/cicle-nous-farmacs-COFB-balboa-2.jpg\" width=\"298\" height=\"199\" \/><\/a><figcaption id=\"caption-attachment-21035\" class=\"wp-caption-text\">El doctor Balboa a la confer\u00e8ncia sobre els f\u00e0rmacs per al tractament de la s\u00edndrome de l\u2019intest\u00ed irritable (SII)<\/figcaption><\/figure>\n<p><b><div class=\"box shadow\"><\/b>La\u00a0s\u00edndrome de l&#8217;intest\u00ed irritable (SII) \u00e9s una de les patologies digestives m\u00e9s freq\u00fcents, que pot afectar a m\u00e9s del 10% de la poblaci\u00f3 general i que, malgrat el seu bon pron\u00f2stic, provoca una important afectaci\u00f3 de la qualitat de vida relacionada amb la salut als pacients que la pateixen.<\/p>\n<p>\u201cNo \u00e9s f\u00e0cil viure amb SII i realment les alteracions que pot provocar s\u00f3n tan variades que possiblement un pacient amb SII sigui el menys semblat quant a s\u00edmptomes que un altre pacient amb SII&#8221;, explica el doctor <strong>Agust\u00edn Balboa<\/strong>. \u201cQualsevol novetat, tant quant a h\u00e0bits higi\u00e8nico-diet\u00e8tics -sabem ara que l&#8217;exercici, o determinades dietes poden ajudar a alguns d&#8217;aquests pacients-, o tractaments farmacol\u00f2gics, ser\u00e0 benvinguda\u201d matisa Balboa. A banda dels ja coneguts antidiarreics i els laxants per al restrenyiment, \u201cpotser el m\u00e9s interessant en els \u00faltims anys sigui la demostraci\u00f3 que un<strong> f\u00e0rmac emprat per al tractament de la hipercolesterol\u00e8mia, com \u00e9s la resincolestiramina, ha resultat molt efica\u00e7 en el control de la diarrea d&#8217;alguns pacients amb SII<\/strong>\u201d. Pel que fa als pacients amb restrenyiment destaca \u201cla recent<strong> arribada de linaclotida<\/strong>, un f\u00e0rmac d&#8217;acci\u00f3 t\u00f2pica -no s&#8217;absorbeix- i que actua com a laxant i com analg\u00e8sic al c\u00f2lon&#8221;. I puntualitza: &#8220;tots dos han estat ben rebuts entre el col\u00b7lectiu de gastroenter\u00f2legs\u201d.<\/p>\n<p>La sala de confer\u00e8ncies estava plena durant la seva xerrada: &#8220;l&#8217;audi\u00e8ncia va participar en les preguntes i va demostrar un gran inter\u00e8s en el tema. En aquest sentit, \u00e9s d&#8217;agrair que una iniciativa com aquests cursos de formaci\u00f3 siguin acollits de forma tan entusiasta\u201d conclou Balboa.<b><\/div><\/b><\/p>\n<p>El cicle de confer\u00e8ncies va estar coordinat per <b>Cristina Rodr\u00edguez<\/b>, cap del Departament de Formaci\u00f3 i Desenvolupament Professional del COF de Barcelona.<\/p>\n<p align=\"right\"><b>Amb la col\u00b7laboraci\u00f3 de:<\/b><\/p>\n<p align=\"right\"><b>Primera sessi\u00f3<\/b><\/p>\n<p align=\"right\"><b><a href=\"http:\/\/www.lundbeck.com\/es\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright  wp-image-21027\" alt=\"lundbeck\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2016\/04\/lundbeck.png\" width=\"143\" height=\"61\" \/><\/a><\/b><\/p>\n<p align=\"right\">\n<p align=\"right\">\n<p align=\"right\"><b>Segona sessi\u00f3<\/b><\/p>\n<p align=\"right\"><b><a href=\"https:\/\/www.boehringer-ingelheim.es\/\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-full wp-image-7441\" alt=\"boehringer\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2014\/07\/boehringer.jpg\" width=\"150\" height=\"45\" \/><\/a><br \/>\n<\/b><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cada any surten nous f\u00e0rmacs al mercat i el farmac\u00e8utic compta amb un ampli estoc de productes destinats a diferents simptomatologies i malalties. Com a professional sanitari, el farmac\u00e8utic ha de saber qu\u00e8 aporten de nou aquests f\u00e0rmacs per proporcionar el millor consell. Per ampliar informaci\u00f3 sobre les noves mol\u00e8cules [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":21022,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[2388,883,270,211,79,612,54,2389,1004,2390,2391],"class_list":["post-20997","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-alcoholisme","tag-ansiolitics","tag-antidepressius","tag-asma","tag-dermatologia","tag-farmacologia","tag-farmacs","tag-intesti-irritable","tag-mpoc","tag-patologia-dermatologica","tag-sii"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Qu\u00e8 en sabem dels f\u00e0rmacs nous? - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Qu\u00e8 en sabem dels f\u00e0rmacs nous? - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Cada any surten nous f\u00e0rmacs al mercat i el farmac\u00e8utic compta amb un ampli estoc de productes destinats a diferents simptomatologies i malalties. Com a professional sanitari, el farmac\u00e8utic ha de saber qu\u00e8 aporten de nou aquests f\u00e0rmacs per proporcionar el millor consell. Per ampliar informaci\u00f3 sobre les noves mol\u00e8cules [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-05-06T09:52:12+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Qu\u00e8 en sabem dels f\u00e0rmacs nous?\",\"datePublished\":\"2016-05-06T09:52:12+00:00\",\"dateModified\":\"2016-05-06T09:52:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/\"},\"wordCount\":1115,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"alcoholisme\",\"ansiol\u00edtics\",\"antidepressius\",\"asma\",\"dermatologia\",\"farmacologia\",\"f\u00e0rmacs\",\"intest\u00ed irritable\",\"MPOC\",\"patologia dermatol\u00f2gica\",\"SII\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/\",\"name\":\"Qu\u00e8 en sabem dels f\u00e0rmacs nous? - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2016-05-06T09:52:12+00:00\",\"dateModified\":\"2016-05-06T09:52:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Qu\u00e8 en sabem dels f\u00e0rmacs nous?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Qu\u00e8 en sabem dels f\u00e0rmacs nous? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/","og_locale":"ca_ES","og_type":"article","og_title":"Qu\u00e8 en sabem dels f\u00e0rmacs nous? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Cada any surten nous f\u00e0rmacs al mercat i el farmac\u00e8utic compta amb un ampli estoc de productes destinats a diferents simptomatologies i malalties. Com a professional sanitari, el farmac\u00e8utic ha de saber qu\u00e8 aporten de nou aquests f\u00e0rmacs per proporcionar el millor consell. Per ampliar informaci\u00f3 sobre les noves mol\u00e8cules [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2016-05-06T09:52:12+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Qu\u00e8 en sabem dels f\u00e0rmacs nous?","datePublished":"2016-05-06T09:52:12+00:00","dateModified":"2016-05-06T09:52:12+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/"},"wordCount":1115,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#primaryimage"},"thumbnailUrl":"","keywords":["alcoholisme","ansiol\u00edtics","antidepressius","asma","dermatologia","farmacologia","f\u00e0rmacs","intest\u00ed irritable","MPOC","patologia dermatol\u00f2gica","SII"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/","url":"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/","name":"Qu\u00e8 en sabem dels f\u00e0rmacs nous? - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#primaryimage"},"thumbnailUrl":"","datePublished":"2016-05-06T09:52:12+00:00","dateModified":"2016-05-06T09:52:12+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2016\/05\/06\/que-en-sabem-dels-farmacs-nous\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Qu\u00e8 en sabem dels f\u00e0rmacs nous?"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Cada any surten nous f\u00e0rmacs al mercat i el farmac\u00e8utic compta amb un ampli estoc de productes destinats a diferents simptomatologies i malalties. Com a professional sanitari, el farmac\u00e8utic ha de saber qu\u00e8 aporten de nou aquests f\u00e0rmacs per proporcionar el millor consell. Per ampliar informaci\u00f3 sobre les noves mol\u00e8cules [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/20997","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=20997"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/20997\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=20997"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=20997"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=20997"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}